Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Small-Cap · Voya

Nomura Small Cap Growth Fund Class A (WSGAX)

Ticker WSGAX · · Holdings as of Jun 30, 2026

Expense ratio
1.1%$110/yr per $10k
5-yr return
+0.8%annualized
1-yr return
+7.1%as of Dec 2025
Net assets
$1.2Ball share classes
Holdings
84

Bottom line

Is WSGAX a good fund? The bottom line

WSGAX is the Class A share class of Nomura Small Cap Growth Fund, an actively managed small-cap mutual fund from Voya.

Annual fees run 1.1% — about $110 a year on every $10,000 invested, more expensive than 60% of small-cap funds we track.

It returned +7.1% over one year, +0.8% a year over five years, +9.2% a year over ten (as of Dec 31, 2025, per its prospectus).

With $1.2 billion in net assets and 84 holdings, its largest position is Mirum Pharmaceuticals Inc (2.3%) and the top 10 make up 20.8% of the portfolio.

This share class carries a front-end sales charge of up to 5.75%; a no-load class or ETF alternative can avoid it.

What to watch

  • 5-year return in the bottom quarter of its category
  • Front-end sales load up to 5.75%
  • 12b-1 marketing fee of 0.25% a year

Updated Nov 19, 2026

What WSGAX invests in

Nomura Small Cap Growth Fund seeks to provide growth of capital.

Nomura Small Cap Growth Fund ?seeks to achieve its objective by investing, under normal circumstances, at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in common stocks of small-capitalization, growth-oriented companies (80% policy). For purposes of the Funds 80% policy, the Manager considers small-capitalization companies to be those companies with market capitalizations similar to those of issuers included in the Russell 2000 Growth Index. As of June 30, 2026, this range of market capitalization was between approximately $157.7 million and $13.8 billion. For purposes of the 80% policy, growth-oriented companies are those companies included in the Russell 2000 Growth Index or companies that exhibit characteristics similar to those companies included in the Russell 2000 Growth Index, including but not limited to relatively higher price-to-book…

From the fund's prospectus (filed Jul 29, 2026).

WSGAX performance

Fund calendar-year total returns, 2015–2025 2015: −2.2%; 2016: +13.4%; 2017: +23.7%; 2018: −4.1%; 2019: +23.8%; 2020: +38.5%; 2021: +4.0%; 2022: −27.7%; 2023: +13.3%; 2024: +14.2%; 2025: +13.6% −2% 2015 +13% 2016 +24% 2017 −4% 2018 +24% 2019 +38% 2020 +4% 2021 −28% 2022 +13% 2023 +14% 2024 +14% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
WSGAX+7.1%+0.8%+9.2%
Small-Cap median+7.6%+7.0%+9.2%

Source: Fund prospectus, as of Dec 31, 2025

Full WSGAX performance history →

What WSGAX costs

On a $10,000 investment, WSGAX's 1.1% expense ratio costs about $110 a year. The prospectus estimates $2,036 in total costs over 10 years (assuming 5% annual returns). The median small-cap fund charges 0.99%.

See the full WSGAX fee table →

WSGAX top 10 holdings

#Holding% of fund
1Mirum Pharmaceuticals Inc MIRM2.34%
2Pricesmart Inc PSMT2.23%
3Digitalocean Holdings Inc DOCN2.17%
4Firstcash Holdings Inc FCFS2.12%
5Kontoor Brands Inc KTB2.08%
6Agilysys Inc AGYS1.99%
7Adaptive Biotechnologies Corp ADPT1.99%
8Advanced Energy Industries Inc AEIS1.97%
9Encompass Health Corp EHC1.96%
10A10 Networks Inc ATEN1.93%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 20.8% of the fund. See all top 25 holdings and asset mix →

Alternatives to WSGAX

More funds like WSGAX →

WSGAX FAQ

What is the expense ratio of WSGAX?
WSGAX's expense ratio is 1.1%, which works out to about $110 a year for every $10,000 invested. The prospectus estimates total costs of $2,036 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is WSGAX a good investment?
It depends on your goals, but the data points to: 5-year return in the bottom quarter of its category; front-end sales load up to 5.75%; 12b-1 marketing fee of 0.25% a year. This is general information, not personalized advice.
What does WSGAX hold?
WSGAX's largest holdings are Mirum Pharmaceuticals Inc (2.3%), Pricesmart Inc (2.2%), Digitalocean Holdings Inc (2.2%), Firstcash Holdings Inc (2.1%), Kontoor Brands Inc (2.1%). It holds 84 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
What is WSGAX's 5-year return?
WSGAX returned +0.8% a year over the five years ending Dec 31, 2025, and +9.2% a year over ten years. Past performance does not guarantee future results.
Does WSGAX have a sales load?
Yes. WSGAX has a maximum front-end sales charge of 5.75%.
Who manages WSGAX?
WSGAX is offered by Voya through Ivy Funds.